immunosuppressant therapeutic drug monitoring ivds
abbott australasia pty ltd diagnostic division - ct866 - immunosuppressant therapeutic drug monitoring ivds - for the determination of immunosuppressant drug levels in human clinical specimens.
instrument/analyser ivds
abbott australasia pty ltd diagnostic division - ct943 - instrument/analyser ivds - instrument and analyser ivd
multiple clinical chemistry constituent ivds
abbott australasia pty ltd diagnostic division - ct889 - multiple clinical chemistry constituent ivds - for the determination of multiple analytes from more than one clinical chemistry specialisty, in human clinical specimens
specimen receptacle ivds
abbott australasia pty ltd diagnostic division - ct936 - specimen receptacle ivds - specimen receptacle and/or accessory for the collection of human specimens
general laboratoryware ivds
abbott australasia pty ltd diagnostic division - ct945 - general laboratoryware ivds - general laboratoryware intended to be used specifically as an ivd in the testing of clincal specimens.
creatine kinase ivds
abbott australasia pty ltd diagnostic division - ct831 - creatine kinase ivds - for the determination of creatine kinase in human clinical specimens.
clinical chemistry therapeutic drug monitoring ivds
abbott australasia pty ltd diagnostic division - ct860 - clinical chemistry therapeutic drug monitoring ivds - for the determination of therapeutic drug levels in human clinical specimens.
instrument/analyser ivds
abbott australasia pty ltd diagnostic division - ct943 - instrument/analyser ivds - instrument/analyser intended to be used as an in-vitro diagnostic medical device(ivd)
software ivds
abbott australasia pty ltd diagnostic division - ct944 - software ivds - software intended to influence an ivd instrument
architect anti-hbs assay - hepatitis b virus surface total antibody ivd, kit, chemiluminescent immunoassay
abbott australasia pty ltd diagnostic division - 48316 - hepatitis b virus surface total antibody ivd, kit, chemiluminescent immunoassay - the architect anti-hbs assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in clinical specimens. a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in clinical specimens.